Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Guy de Bruyn, David L. Gordon, Theodore Steiner, Paul Tambyah, Catherine Cosgrove, Mark Martens, Ehab Bassily, Eng Soon Chan, Dhaval Patel, Josh Chen, Julian Torre-Cisneros, Carlos Fernando De Magalhães Francesconi, Richard Gesser, Robert Jeanfreau, Odile Launay, Thelma Laot, Rayo Morfin-Otero, Ernesto Oviedo-Orta, Yoon Soo Park, Franco M. PiazzaChristine Rehm, Enrique Rivas, Steve Self, Sanjay Gurunathan

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences